Literature DB >> 15026782

Haplotype study in Dutch SCA3 and SCA6 families: evidence for common founder mutations.

Dineke S Verbeek1, Sytse J Piersma, Eric F A M Hennekam, Elly F Ippel, Peter L Pearson, Richard J Sinke.   

Abstract

This pilot study was initiated to show the existence of founder effects in the Dutch autosomal dominant cerebellar ataxia (ADCA) population. The ADCAs comprise a clinically heterogeneous group of neurodegenerative disorders and the estimated prevalence in the Netherlands is approximately 3:100 000 individuals. Here, we focused on the SCA3 and SCA6 genes because mutations in these genes occur most frequently in the Netherlands. We were able to determine a common origin of the CAG repeat expansions in the majority of Dutch SCA3 and SCA6 families. Haplotype analysis and linkage disequilibrium studies with polymorphic markers revealed shared haplotypes surrounding the SCA3 and SCA6 genes. These results strongly suggest that ADCA families can be traced back to common ancestors in particular parts of the Netherlands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026782     DOI: 10.1038/sj.ejhg.5201167

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  3 in total

1.  Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population.

Authors:  Dineke S Verbeek; Bart P C van de Warrenburg; F A M Hennekam; Dennis Dooijes; P F Ippel; Corien C Verschuuren-Bemelmans; H P H Kremer; Richard J Sinke
Journal:  Hum Genet       Date:  2005-04-20       Impact factor: 4.132

Review 2.  Mutant Ataxin-3-Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder.

Authors:  Kritika Raj; Ravi Shankar Akundi
Journal:  Mol Neurobiol       Date:  2021-02-24       Impact factor: 5.590

3.  'Costa da Morte' ataxia is spinocerebellar ataxia 36: clinical and genetic characterization.

Authors:  María García-Murias; Beatriz Quintáns; Manuel Arias; Ana I Seixas; Pilar Cacheiro; Rosa Tarrío; Julio Pardo; María J Millán; Susana Arias-Rivas; Patricia Blanco-Arias; Dolores Dapena; Ramón Moreira; Francisco Rodríguez-Trelles; Jorge Sequeiros; Angel Carracedo; Isabel Silveira; María J Sobrido
Journal:  Brain       Date:  2012-04-03       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.